Research progress on small cell lung cancer with syndrome of inappropriate secretion of antidiuretic hormone / 中国肿瘤临床
Chinese Journal of Clinical Oncology
;
(24): 233-237, 2017.
Article
in Chinese
| WPRIM
| ID: wpr-509733
ABSTRACT
Many malignant tumors, most commonly small cell lung cancer, merge with syndrome of inappropriate secretion of antidi-uretic hormone (SIADH). SIADH is caused by the neuroendocrine function of tumor cells or is a side effect of chemotherapeutics. As a chemotherapeutic side effect, SIADH presents as hyponatremia. Therapy for SIADH includes both treatment for primary diseases and hyponatremia. Given that SIADH-induced hyponatremia aggravates the prognosis and shortens the survival time of patients with malig-nant tumors, SIADH is an independent risk factor for prognosis. Therefore, the early diagnosis, monitoring, and treatment of SIADH will improve the prognosis of patients with malignant tumors.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Risk factors
/
Screening study
Language:
Chinese
Journal:
Chinese Journal of Clinical Oncology
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS